John Doty, MD
Critical Care Medicine · Charlotte, NCNPI 1992786081
Payments from drug & device makers
What this record shows
This record is dominated by education: $25,013 of the $37,151 with a category attached, or 67.3%. Intuitive Surgical accounts for 93.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $15,133 and has fallen 64.9% since, to $5,307 in 2025. Among critical care medicine clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $417.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$35K
- Johnson & Johnson$1K
- Medtronic$465
- Atricure, Inc.$254
- Covidien LP$76
- Siemens Medical Solutions USA, Inc.$71
- plus $431 from 15 others
What the payments were for
- Speaking & faculty fees$3,4209%
- Travel & lodging$4,74213%
- Food & beverage$3,97711%
- Education$25,01367%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 54 | $34,749 |
| Johnson & Johnson | 5 | $1,105 |
| Medtronic | 5 | $465 |
| Atricure, Inc. | 3 | $254 |
| Covidien LP | 1 | $76 |
| Siemens Medical Solutions USA, Inc. | 1 | $71 |
| Sanofi | 3 | $65 |
| Galvanize Therapeutics, Inc | 1 | $57 |
| Melinta Therapeutics, LLC | 3 | $53 |
| Pulmonx Corporation | 1 | $38 |
| GSK | 2 | $37 |
| Amgen | 1 | $24 |
| Grifols USA, LLC | 1 | $22 |
| Baxter Healthcare | 1 | $22 |
| Insmed, Inc. | 1 | $20 |
| Novartis | 1 | $20 |
| United Therapeutics Corporation | 1 | $19 |
| AstraZeneca | 1 | $16 |
| Boston Scientific | 1 | $13 |
| Merck | 1 | $13 |
| Fisher & Paykel Healthcare Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,151 in reported general payments places this provider in the 95th percentile of 190 critical care medicine providers in North Carolina.
See all critical care medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 111 | $93,799 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 42 | $27,461 |
| Spiriva HandihalerTiotropium Bromide | 20 | $15,779 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $13,206 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 11 | $12,861 |
| Advair HfaFluticasone Propion/Salmeterol | 19 | $9,589 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $9,439 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 24 | $3,985 |
| Itraconazole | 12 | $3,302 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 106 | $2,696 |
| Ventolin HfaAlbuterol Sulfate | 20 | $981 |
| Azithromycin | 14 | $509 |
| Doxycycline Hyclate | 38 | $315 |
| Fluticasone Propionate | 15 | $315 |
| Levofloxacin | 17 | $310 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $37 | $130,699168 claims |
| AstraZenecaBreztri Aerosphere | $16 | $13,20617 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 190 critical care medicine providers in North Carolina.
Other critical care medicine in Charlotte
- Rabih BecharaCharlotte$453K
- Alan HeffnerCharlotte$326K
- Alfred PapaliCharlotte$10K
- Amar PanchalCharlotte$8K
- Lacey SpanglerCharlotte$3K
- Jeffrey WallsCharlotte$2K
- Sachin HansaliaCharlotte$2K
- Luke NeilansCharlotte$2K
- Kimberly McCreaCharlotte$2K
- James RobertsCharlotte$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.